Moneycontrol
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Samrat Pharmachem

BSE: 530125|ISIN: INE103E01016|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Aug 18, 16:00
55.20
1.7 (3.18%)
VOLUME 302
Samrat Pharmachem is not listed on NSE
Announcements on Samrat Pharma

5th-Aug-2017 15:46Source: BSE

Samrat Pharma- Closure of Trading Window

Earlier notice dated July 14, 2017 for convening Board Meeting & Closure of Trading Window stands cancelled.

Further, in terms of the SEBI (Prohibition of Insider Trading) Regulations, 2015...

5th-Aug-2017 15:44Source: BSE

Samrat Pharma- Intimation Of Postponement Of Meeting Of The Board Of Directors For Approval Of Unaudited Financial Results For The Quarter Ended June 30, 2017

In order to facilitate smooth transition during the first year of Ind-AS implementation, the Securities and Exchange Board of India vide its Circular No. CIR/CFD/FAC/62/2016 Dated July 5, 2016, has gr...

1st-Aug-2017 14:08Source: BSE

Samrat Pharma- Financial Results For Mar 31, 2017

Financial Results for Mar 31, 2017

21st-Jul-2017 12:48Source: BSE

Samrat Pharma- Shareholding for the Period Ended June 30, 2017

Samrat Pharmachem Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2017. For more details, kindly

21st-Jul-2017 12:44Source: BSE

Samrat Pharma- Statement Of Investor Complaints For The Quarter Ended June, 2017

This is to inform you that the company has received Nil Investor grievances for the quarter ended 30th June, 2017 as required under Regulation 13(3) of the SEBI (Listing Obligation and Disclosure Requ...

14th-Jul-2017 16:18Source: BSE

Samrat Pharma- Board Meeting On August 14, 2017

Pursuant to Regulation 29(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, notice is hereby given that a meeting of the Board of Directors of the Company will be hel...

14th-Jul-2017 15:54Source: BSE

Samrat Pharma- Closure of Trading Window

In terms of the SEBI (Prohibition of Insider Trading) Regulations, 2015, and as per the terms of ''Code of Conduct for Prevention of Insider Trading'' of the Company, the Trading Window of the Company...

31st-May-2017 07:36Source: BSE

Samrat Pharma- Financial Results For March 31, 2017

Financial Results for March 31, 2017

20th-Apr-2017 15:46Source: BSE

Samrat Pharma- Compliance Certificate For The Period Ended March, 2017

Compliance Certificate - Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 for the period ended March, 2017

18th-Apr-2017 14:44Source: BSE

Samrat Pharma- Compliance Certificate Under Regulation 40(9), (10) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, For The Half Year Ended March 31, 2017

Compliance Certificate under Regulation 40(9), (10) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the Half Year ended March 31, 2017

1 2 3 4 5 Next >>
Board Meeting (Samrat Pharma)

Meeting Date

Remark

2017-09-13

Quarterly Results

Quick Links for Samrat Pharmachem
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.